On Thursday, September 24, 2026, the global healthcare ecosystem changed forever. We analyze Alibaba's open-source medical foundation model that shatters cloud monopolies and saves lives with unprecedented accuracy.
In one of the most transformative, hopeful, and scientifically momentous turning points in the history of computational biology and modern clinical oncology, the boundaries of early cancer detection have
been fundamentally redrawn. Researchers and biomedical engineers at Alibaba DAMO Academy, working in rigorous multi-center clinical collaboration with The First Affiliated Hospital of Zhejiang University
School of Medicine, have achieved a milestone that has left the international medical and technological communities in awe. Published as a featured research article in the September 2026 issue of the prestigious
journal Science , the team unveiled Damo Radar (formally designated as RADAR ) the world's first expert-level, generalist foundation artificial intelligence model specifically engineered for whole-abdomen
computed tomography (CT) diagnostics. Operating across 18 anatomical organs simultaneously, Damo Radar is capable of screening, segmenting, and clinically classifying nearly 150 distinct abdominal pathologies
and malignant neoplasms with diagnostic precision that eclipses human specialist benchmarks. From occult pancreatic ductal adenocarcinomas and early-stage hepatocellular carcinomas to intricate renal cell
variants, gastric wall infiltrations, and mesenteric vascular occlusions, this singular neural network solves an image-recognition challenge that has defeated legacy computer-aided detection (CAD) systems
for over three decades. Yet the sheer diagnostic accuracy of Damo Radar is only half of this historic narrative. In an unprecedented move that breaks decisively with the prevailing Silicon Valley paradigm
Read Full Article